SEC Form 4 · accession 0001209191-19-005359
CHIMERIX INC · CMRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Garrett Nichols
Officer — Chief Medical Officer
Period of report
Jan 23, 2019
Accepted (ET)
Jan 25, 2019 · 4:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001117480
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 23, 2019 | A | 125,000 | $0.00 | A | 215,471 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $2.41 | Jan 23, 2019 | A | 200,000 | A | — | Jan 22, 2029 | Common Stock | 200,000 | 200,000 | D |
Explanation of responses
- F1The shares being reported are being issued pursuant to restricted stock unit awards ("RSUs"), each one of which represents a contingent right to receive one share of the Issuer's common stock. 25,000 shares subject to the RSUs will vest on the six-month anniversary of the date of grant, 25,000 shares subject to the RSUs will vest on the one-year anniversary of the date of grant, 25,000 shares subject to the RSUs will vest on the 18-month anniversary of the date of grant, and 50,000 shares subject to the RSUs will vest on the two-year anniversary of the date of grant.
- F21/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.